Certified by Founder Lodge
Dreavent
United States - Cambridge, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $6,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Dreavent is an investment firm focused on Biotech Therapeutics companies. Our strategic location in the preeminent biotech hub, combined with a worldwide network of investors and partners, al
| Company | Date | Round | Raised |
|---|---|---|---|
 Astrocyte Pharmaceuticals |
August, 22 ,2023 | Pre-Series B | $6,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Flashpass | $4,250,000 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)
Zell | $589,875 | (Apr 14, 2026)
Citra Space Corporation | $15,000,000 | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
